Annotation
Evidence for using nebulised antibiotics in cystic fibrosis
| The first 150 words of the full text of this article appear below. |
| |
Introduction |
|---|
Standards of care for patients with cystic fibrosis (CF) have been defined largely on the basis of "best practice", an accolade awarded to treatment regimens showing low chronic pulmonary infection rates, greatest patient longevity, and least patient morbidity. While acknowledging the wisdom accrued through clinical experience, paediatricians caring for children with CF are fighting for limited resources and must convince purchasers, who stroll the fashionable catwalk of evidence based medicine, of the scientific basis of our demands. They ask, "Where's the beef?" For the use of nebulised antibiotics in CF care we can reply only that we have a lot of "topside" but few "prime cuts".
Clinical trials, the results of which affect all of our prescription
practices, have been generally parochial in conception, bedevilled by
small patient numbers, and underpowered, partly reflecting patient
recruitment problems for research into an illness that affects only a
small minority of the population
This article has been cited by other articles:
-
FRANZ, A. R., ROHLKE, W., FRANKE, R. P., EBSEN, M., POHLANDT, F., HUMMLER, H. D.
(2001). Pulmonary Administration of Perfluorodecaline- Gentamicin and Perfluorodecaline- Vancomycin Emulsions. Am. J. Respir. Crit. Care Med.
164: 1595-1600
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



